Switched Aβ43 generation in familial Alzheimer's disease with presenilin 1 mutation

被引:6
|
作者
Kakuda, Nobuto [1 ,2 ]
Takami, Mako [1 ,2 ]
Okochi, Masayasu [3 ]
Kasuga, Kensaku [4 ]
Ihara, Yasuo [1 ]
Ikeuchi, Takeshi [4 ]
机构
[1] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyoto 6100394, Japan
[2] Doshisha Univ, Ctr Res Neurodegenerat Dis, Kyoto 6100394, Japan
[3] Osaka Univ, Grad Sch Med, Div Internal Med, Neuropsychiat & Neurochem,Dept Integrated Med, Osaka 5650871, Japan
[4] Niigata Univ, Ctr Bioresources, Bioresource Sci Branch, Dept Mol Genet, Niigata 9518585, Japan
关键词
GAMMA-SECRETASE ACTIVITY; AMYLOID-BETA-PROTEIN; INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; SENILE PLAQUES; DEPOSITION; MECHANISM; RELEASE; DOMAIN; ONSET;
D O I
10.1038/s41398-021-01684-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Presenilin (PS) with a genetic mutation generates abundant beta-amyloid protein (A beta) 43. Senile plaques are formed by A beta 43 in the cerebral parenchyma together with A beta 42 at middle ages. These brains cause the early onset of Alzheimer's disease (AD), which is known as familial Alzheimer's disease (FAD). Based on the stepwise processing model of A beta generation by gamma-secretase, we reassessed the levels of A beta s in the cerebrospinal fluid (CSF) of FAD participants. While low levels of A beta 38, A beta 40, and A beta 42 were generated in the CSF of FAD participants, the levels of A beta 43 were unchanged in some of them compared with other participants. We sought to investigate why the level of A beta 43 was unchanged in FAD participants. These characteristics of A beta generation were observed in the gamma-secretase assay in vitro using cells, which express FAD mutations in PS1. A beta 38 and A beta 40 generation from their precursors, A beta 42 and A beta 43, was decreased in PS1 mutants compared with wild-type (WT) PS1, as observed in the CSF. Both the ratios of A beta 38/A beta 42 and A beta 40/A beta 43 in PS1 mutants were lower than those in the WT. However, the ratio of A beta 43/amyloid precursor protein intracellular domain (AICD) increased in the PS1 mutants in an onset age dependency, while other A beta/AICD ratios were decreased or unchanged. Importantly, liquid chromatography-mass spectrometry found that the generation of A beta 43 was stimulated from A beta 48 in PS1 mutants. This result indicates that PS1 mutants switched the A beta 43 generating line, which reflects the level of A beta 43 in the CSF and forming senile plaques.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Alzheimer's disease - Molecular consequences of presenilin-1 mutation
    Gandy, S
    Naslund, J
    Nordstedt, C
    NATURE, 2001, 411 (6838) : 654 - 655
  • [32] Uncommon polymorphism in the presenilin genes in human familial Alzheimer's disease:: not to be mistaken with a pathogenic mutation
    Lleó, A
    Castellví, M
    Blesa, R
    Oliva, R
    NEUROSCIENCE LETTERS, 2002, 318 (03) : 166 - 168
  • [33] Monogenic determinants of familial Alzheimer's disease: Presenilin-1 mutations
    Kovacs, DM
    Tanzi, RE
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (09) : 902 - 909
  • [34] Novel Presenilin 1 Mutations in Italian familial Alzheimer's Disease patients
    Piaceri, I.
    Tedde, A.
    Nacmias, B.
    Bagnoli, S.
    Bracco, L.
    Guarnieri, B. M.
    Sorbi, S.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 : S38 - S38
  • [35] Presenilin-1 protein expression in familial and sporadic Alzheimer's disease
    Levey, AI
    Heilman, CJ
    Lah, JJ
    Nash, NR
    Rees, HD
    Wakai, M
    Mirra, SS
    Rye, DB
    Nochlin, D
    Bird, TD
    Mufson, EJ
    ANNALS OF NEUROLOGY, 1997, 41 (06) : 742 - 753
  • [36] Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations
    D. M. Kovacs
    R. E. Tanzi
    Cellular and Molecular Life Sciences CMLS, 1998, 54 : 902 - 909
  • [37] A pedigree of familial alzheimer disease with spastic paraplegia carrying a novel presenilin-1 mutation
    Oi, Y.
    Itani, M.
    Hasegawa, H.
    Maki, T.
    Kuzuya, A.
    Yamashita, H.
    Niwa, A.
    Takaya, S.
    Okada, T.
    Sawamoto, N.
    Matsumoto, R.
    Ikeda, A.
    Tomimoto, H.
    Takahashi, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1134 - 1135
  • [38] Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine
    Zaman, SH
    Parent, A
    Laskey, A
    Lee, MK
    Borchelt, DR
    Sisodia, SS
    Malinow, R
    NEUROBIOLOGY OF DISEASE, 2000, 7 (01) : 54 - 63
  • [39] Neuropathology of early onset familial Alzheimer disease associated with the presenilin-1 S169L mutation
    Takao, M
    Murrell, JR
    Giaccone, G
    Evans, R
    Tagliavini, F
    Bugiani, O
    Farlow, MR
    Heyman, A
    Ghetti, B
    BRAIN PATHOLOGY, 2000, 10 (04) : 633 - 634
  • [40] A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy
    Yasuda, M
    Maeda, K
    Ikejiri, Y
    Kawamata, T
    Kuroda, S
    Tanaka, C
    NEUROSCIENCE LETTERS, 1997, 232 (01) : 29 - 32